Akụkọ ọhụrụ nke #WHO gbasara ụkwara nta na-ekpughe eziokwu doro anya: achọpụtara nde mmadụ 8.2 nwere ọrịa TB ọhụrụ na 2023—nke kachasị elu kemgbe mmalite nlekota ụwa niile na 1995. Mmụba a site na nde 7.5 na 2022 weghachiri TB ka ọ bụrụ ọrịa ahụ.onye na-egbu ọrịa na-efe efe, gafere COVID-19.
Ma, nsogbu ka njọ na-egosi mweghachi a:Nguzogide nje bacteria (AMR)WHO na-eme atụmatụ na site na 2050, AMR nwere ike ikwu na ọ ga-erule afọ 2050.ruo nde mmadụ iri kwa afọụwa niile, ebe TB na-eguzogide ọgwụ (DR-TB) bụ ihe na-akpata nsogbu. Na 2019 naanị, AMR gburu mmadụ nde 1.3 ozugbo—karịrị nje HIV/AIDS na ịba jikọtara ọnụ- ma ugbu a ọ bụihe nke atọ kacha akpata ọnwụ n'ụwa niileỌ bụrụ na e tinyeghị aka, ọnụọgụ ọnwụ sitere na AMR nwere ike iruNde 39 ka ọ na-erule afọ 2050, yana mfu akụ na ụba kachasị elu$100 trillion.
Ihe Mere A Na-anaghị Ekwe Nkwurịta Banyere Nchọpụta Oge
Ọgwụgwọ nke TB dabere na nchọpụta ngwa ngwa na usoro ọgwụgwọ ziri ezi. Agbanyeghị, ojiji ọgwụ nje na-adịghị mma emeela ka TB na-eguzogide ọtụtụ ọgwụ (MDR-TB) dịkwuo ngwa ngwa, na-eme ka ọrịa ndị a na-agwọ agwọ bụrụ ihe iyi egwu ọnwụ.
Ọrịa TB na-eguzogide ọgwụ na-akpata 1/3 nke ọnwụ AMR zuru ụwa ọnụ.
Ndị agadi na-eche mmụba nke ọnwụ AMR ihu(elu 80% kemgbe 1990 n'etiti ndị agadi).
Mgbanwe ihu igwe nwere ikeKa ọ na-erule afọ 2050, mmụba nke AMR na-aka njọ site na 2.4%, na-emetụta mpaghara ndị na-enweta obere ego n'ụzọ na-ezighi ezi.
WHO kpọrọ oku ngwa ngwa ka e mepụta ihe ọhụrụ n'inyocha ngwa ngwa iji lụso mmejọ ọgụ na imechi oghere ọgwụgwọ
Ngwa TB atọ nke Macro & Micro-Test nke CE-Certified: Ngwaọrụ nkenke maka oge AMR
Ngwọta anyị kwekọrọ na atụmatụ njide AMR nke WHO site n'itinye aka nanchọpụta n'otu oge nke ọrịa TB + rifampicin (RIF) + iguzogide isoniazid (INH)—dị oke mkpa maka igbochi DR-TB.
Isi Atụmatụ:
Ọsọ na Izi ezi: Nsonaazụ n'ime awa 2–2.5 yana nkọwa akpaka (ọ dị mkpa ka a zụọ obere ọzụzụ).
Ebumnuche zuru oke:TB: IS6110 mkpụrụ ndụ ihe nketa
RIF-eguzogide: rpoB (507~533)
Mgbochi INH: InhA, AhpC, katG 315
Nnukwu Mmetụta: Ọ na-achọpụta nje bacteria iri/mL (TB) na nje bacteria 150–200/mL maka ihe nrịbama ndị na-eguzogide ọgwụ.
Ndị na-agbaso iwu WHO: Na-emezu ntuziaka maka njikwa DR-TB.
Ndakọrịta sara mbara: Na-arụ ọrụ na sistemụ PCR dị mkpa (dịka ọmụmaatụ, Bio-Rad CFX96, SLAN-96P/S).
Ihe Mere Nke a Ji Dị Mkpa:
Nchọpụta ngwa ngwa nke mkpụrụ ndụ ihe nketa ndị na-eguzogide ọgwụ na-egbochi ojiji ọgwụ nje na-adịghị arụ ọrụ nke ọma, na-ebelata mbufe nje,
Oku maka Ihe
Njikọta nke mweghachi nke TB na AMR chọrọ ngwaọrụ ndị na-ejikọ ọsọ na nkenke. Ngwa anyị na-ejikọ oghere a - hụ na ọgwụgwọ malitere nke ọma, na nke mbụ.
Mụtakwuo:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisonazid-resistance-product/
Kpọtụrụ:marketing@mmtest.com
#IVD #PCR #AMRCrisis #Ọgwụ Mgbochi #TB #ỌgwụgwụTB #MDRTB #Nchọpụta #Ahụike Ụwa #WHO #Nnwale MicroMicro
Oge ozi: Nọvemba-25-2025